An official website of the United States government
The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before
sharing sensitive information, make sure you’re on a federal
government site.
The site is secure.
The https:// ensures that you are connecting to the
official website and that any information you provide is encrypted
and transmitted securely.
1 Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.
2 Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
3 Radiology Department, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
4 Department Laboratory Haematology, Center for Thrombosis and Haemostasis, Nouvel Hôpital Civil Strasbourg University Hospital, Strasbourg, France.
5 Department of Internal Medicine, Médicale B, Strasbourg University Hospital, Strasbourg, France.
6 Department of Internal Medicine, Diabetes and Metabolic Disorders, Strasbourg University Hospital, Strasbourg, France.
7 Department of Infectious Disease, Strasbourg University Hospital, Strasbourg, France.
8 National Referral Center for Systemic Autoimmune Diseases, Clinical Immunology Department, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
9 Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France. Electronic address: olivier.morel@chru-strasbourg.fr.
1 Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France.
2 Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
3 Radiology Department, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
4 Department Laboratory Haematology, Center for Thrombosis and Haemostasis, Nouvel Hôpital Civil Strasbourg University Hospital, Strasbourg, France.
5 Department of Internal Medicine, Médicale B, Strasbourg University Hospital, Strasbourg, France.
6 Department of Internal Medicine, Diabetes and Metabolic Disorders, Strasbourg University Hospital, Strasbourg, France.
7 Department of Infectious Disease, Strasbourg University Hospital, Strasbourg, France.
8 National Referral Center for Systemic Autoimmune Diseases, Clinical Immunology Department, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France.
9 Division of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, Strasbourg, France; INSERM (French National Institute of Health and Medical Research), UMR 1260, Regenerative Nanomedicine, FMTS, Strasbourg, France. Electronic address: olivier.morel@chru-strasbourg.fr.
Leukocytes, hemoglobin, platelets and D-Dimers in COVID-19 patients during hospitalization. Biological parameters at…
Fig. 1
Leukocytes, hemoglobin, platelets and D-Dimers in COVID-19 patients during hospitalization. Biological parameters at admission, Nadir/peak values and discharge in COVID-19 patients. Higher leukocyte count and D-Dimer levels were evidence at baseline in VTE patients as compared to non VTE patients. Similarly, higher D-Dimer peak and lower hemoglobin level at discharge were observed in VTE patients. Abbreviations: COVID-19, coronavirus disease 2019; VTE, venous thromboembolism.
Santos-Gallego C.G., Badimon J.J. The sum of two evils: pneumonia and myocardial infarction: is platelet activation the missing link? J. Am. Coll. Cardiol. 2014;64:1926–1928. doi: 10.1016/j.jacc.2014.08.023.
-
DOI
-
PubMed
Klok F.A., Kruip M.J.H.A., van der Meer N.J.M. Incidence of thrombotic complications in critically ill ICU patients with COVID-19. Thromb. Res. 2020;191:145–147. doi: 10.1016/j.thromres.2020.04.013.
-
DOI
-
PMC
-
PubMed
Klok F.A., Kruip M.J.H.A., van der Meer N.J.M. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: an updated analysis. Thromb. Res. 2020;191:148–150. doi: 10.1016/j.thromres.2020.04.041.
-
DOI
-
PMC
-
PubMed
Marchandot B., Sattler L., Jesel L. COVID-19 related coagulopathy: a distinct entity? J. Clin. Med. 2020;9:1651. doi: 10.3390/jcm9061651.
-
DOI
-
PMC
-
PubMed
Heit J.A. The epidemiology of venous thromboembolism in the community: implications for prevention and management. J. Thromb. Thrombolysis. 2006;21:23–29. doi: 10.1007/s11239-006-5572-y.
-
DOI
-
PubMed